As of Q4 2023, Grifols Sa's earnings has grown 3.77% year over year. This is 11.1 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of -7.33%. Grifols Sa's earnings in the past year totalled $226.39 million.
Grifols Sa's earnings date is Invalid Date. Add GRFS to your watchlist to be reminded of GRFS's next earnings announcement.
What was GRFS's revenue growth in the past year?
As of Q4 2023, Grifols Sa's revenue has grown 15.08% year over year. This is 15.28 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of -0.2%. Grifols Sa's revenue in the past year totalled $6.59 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.